new-recommended-broker-banner new-recommended-broker-banner

Symphony Share Price Surges After Presenting Impressive Antiviral Gear Results

Updated: 30 Nov 2020

Shares of Symphony Environmental Technologies PLC (LON: SYM) soared 23.8% today after the company presented an impressive set of results for its antiviral gloves and masks.

In particular, the d2pAM glove showed a 99.99% virus-reduction after only one hour of contact, the data shows. Similarly, the facemask showed a 99% virus-reduction after an hour and 99.9% after two hours.

“These test results are a significant step forward in our global marketing campaign to promote the importance of using our d2p technology in these everyday essential products,” Symphony chief executive, Michael Laurier said.


“We believe this is a major breakthrough in the fight against COVID. These masks and gloves will provide essential additional protection for everyone, especially for staff, patients, and visitors in a hospital or care-home environment.”

Symphony used the Laboratory of Virology at the University of Campinas in Brazil for testing its gear against the family of viruses, namely SARS-CoV-1, SARS-CoV-2/COVID-19 and MERS.

Symphony share price gains on impressive Covid-19 gear test results November 2020

Symphony share price initially skyrocketed nearly 24% to hit a one-month high at 26p. The price action now trades at 22.6p, up 7.14%.


CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .